Followers

Friday, May 15, 2009

Why We Don't Trust Pharmaceutical Companies

Pharmaceutical powerhouse Merck & Co. recently paid the Australian branch of Elsevier, a company that publishes a wide range of scholarly journals, to put together a bogus journal for them. This is bad behaviour on the part of both companies. No one is really all that surprised about Merck, I take it. But Elsevier should know better.

Physician & columnist, Ben Goldacre, has this nice summary of the situation: Elsevier get into fanzines.

Hat tip to Chris MacDonald.

No comments: